EBMT enters the week after a clean Q1 earnings beat — and the market's reaction has pushed the stock to its best level in months.
Q1 results, reported April 28, came in at $0.51 per diluted share, beating the consensus estimate of $0.46 by six cents. Net income hit $4.0 million. Revenue missed at $18.7 million against a $20.8 million forecast, but the per-share beat was strong enough to drive a 3.4% one-day gain. That followed a week where the stock already added 4.5%, putting the one-month move at over 12% to close at $22.76. The bank also declared a quarterly cash dividend of $0.145 per share and renewed its stock repurchase plan — both signals that management is comfortable with capital levels heading into mid-year.
Short sellers read the setup ahead of time. Short interest has fallen roughly 11% over the week and 24.5% over the past month, pulling back to about 1.8% of the free float — a level that barely registers as a short thesis. The lending market backs that up: availability is at more than 5,200% of short interest, meaning shares to borrow are essentially unlimited relative to demand. Cost to borrow has eased to below 0.9% after a brief spike toward 3.6% in early April — likely a tariff-volatility blip — and the ORTEX short score has edged lower all week, settling at 31.8. This is not a name with active short pressure.
The single active analyst voice belongs to DA Davidson, which moved its price target up to $24 from $22 on April 29, the day after results, while maintaining a Neutral rating. The target is close to the current price, making the setup fairly valued in the Street's one-analyst view. Factor scores point to notable EPS momentum — the 30-day reading ranks in the 91st percentile — which is the clearest quantitative support for the post-earnings move. The price-to-book ratio has expanded to 0.88x, up roughly 10% over the past month as the stock rallied, though it remains below book value. The P/E runs at 10.98x. Dividend history data in the system is stale, but the newly declared $0.145 quarterly dividend confirms the payout remains intact.
Institutional ownership is spread across the usual index and quant shops, with BlackRock holding around 6.5%, Vanguard near 5.5%, and Brandes Investment Partners at 5.3%. None of those flows are dramatic. The insider picture is worth a brief note: several directors sold small positions in February, in the $22-$23 range — modest, low-significance transactions that likely reflect personal liquidity rather than any strategic read on the stock. Net insider activity over the 90 days through February 20 ran slightly positive at roughly 21,000 shares, but that figure is skewed by routine equity awards to the CFO and a senior VP in early February.
The next earnings date is scheduled for July 23. Between now and then, what matters most is whether net interest margin holds up as the rate environment shifts and whether loan growth can close the gap between the EPS beat and the revenue miss.
See the live data behind this article on ORTEX.
Open EBMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
